Original Article
Target site modification is mediated by rRNA methylases encoded by the ermB gene or ermTR gene of the ermA class and related to the MLS phenotype (resistance to macrolide, lincosamide and streptogramin B). The expression of these genes may be constitutive (cMLS) or inducible (iMLS). The second mechanism is by an efflux pump encoded by the mefA gene which is related to the M phenotype (resistance to 14 and 15 membered ring macrolides). Other minor resistance mechanisms are mutations in the 23SrRNA gene and alterations in riboproteins L4 and L22. [6] Although tetracyclines are not used for treating GAS diseases, high tetracycline resistance has been reported in many countries. Co-occurrence of tetracycline and macrolide resistance has been reported as tetracycline resistance genes can reside on mobile genetic elements that carry macrolide resistance genes. [7, 8] Resistance to tetracycline is conferred by ribosome protection genes such as tetM and tetO and by efflux pumps encoded by tetK or tetL genes. [9] The present study aimed to determine the prevalence of antibiotic resistance among GAS isolates and the underlying genetic mechanisms.
matErials anD mEtHODs
The study included a total of 206 GAS isolates from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, isolated from various clinical samples between November 2013 and October 2017. Non-invasive infections such as superficial skin infections and pharyngitis contributed to 71% (n = 147), while 29% were invasive infections such as sepsis, necrotising fasciitis, osteomyelitis and septic arthritis. The age of the patients ranged from 13 days to 80 years, with a mean of 35.5 ± 22.3 years (standard deviation). Males (62%) were predominant in the study population when compared to females (38%). The proportion of invasive infections was much higher in patients aged above 60 years while non-invasive infections predominated in the younger age group.
Identification was done by routine laboratory techniques such as bacitracin sensitivity, PYR test and latex agglutination (STREP Test kit, Plasmatec, Dorset, UK) and confirmed by SPY1258 polymerase chain reaction (PCR). Bacterial DNA was extracted using Mericon DNA Bacteria plus kit (Qiagen, Germany) according to the manufacturer's instructions. The study was approved by JIPMER Scientific Advisory Sub-Committee (No. JSASC/01/2014) and Institute Human Ethics Committee (No. JIP/IEC/SC/2014/3/555).
Antibiotic susceptibility testing
The isolates were tested for susceptibility to penicillin (10 units), erythromycin (15 µg), clindamycin (2 µg), tetracycline (30 µg), vancomycin (30 µg) and linezolid (30 µg) by Kirby-Bauer disc diffusion method using Muller-Hinton sheep blood agar and the results were interpreted according to the CLSI guidelines. [10] 
Determination of the macrolide-resistant phenotype
The erythromycin-resistant phenotypes were determined by a double-disc test involving erythromycin (15 µg) and clindamycin (2 µg) discs placed 15-20 mm apart (edge to edge). Three different patterns were observed following the test, viz. M (erythromycin resistant and clindamycin susceptible), cMLS (constitutive erythromycin and clindamycin resistant) and iMLS (erythromycin resistant and clindamycin inducibly resistant). Blunting of the clindamycin inhibition zone near to the erythromycin disc indicates an iMLS phenotype, whereas susceptibility to clindamycin with no blunting indicates the M phenotype. [11] 
Minimum inhibitory concentration determination
Minimum inhibitory concentration (MIC) of penicillin, erythromycin and tetracycline was determined by E-test, according to the manufacturer's instructions (BioMérieux). Direct colony suspension method was used. The inoculum was adjusted to 0.5 McFarland standard, using colonies from an overnight sheep blood agar plate. The suspension was inoculated onto Mueller-Hinton agar medium with 5% sheep blood. E-test strips were placed on the plate using sterile forceps, and the plates were incubated at 37°C for 20-24 h. MIC reading was taken as the point of intersection of the zone of inhibition of growth and the E-test strip. The results were interpreted according to the CLSI guidelines. [10] 
Detection of erythromycin-and tetracycline resistance genes
Two multiplex PCRs were carried out in 25 µl volume to detect the presence of erythromycin resistance genes ermB, ermA and mefA and tetracycline resistance genes tetM, tetO, tetK and tetL using specific primers as previously described. [9, 12] The reaction mix contained 2 × Taq PCR Smart Mix (Origin, Karunagappalli, Kerala, India), 10 pmol of each primer and 10 ng of sample DNA. The 16SrRNA gene specific for genus Streptococcus was included as an internal control [ Table 1 ].
Quality control
For the gene targets, the amplified products were sequenced, and once confirmed, they were used as positive controls in the subsequent assays.
Statistical analysis
Statistical analysis was carried out using OpenEpi (Open Source Epidemiologic Statistics for Public Health) Version 3.03a (www.openepi.com). Majority of counts have been expressed in percentages; key proportion has been expressed within 95% confidence interval. Chi-square test was used to calculate associations and P ≤ 0.05 was considered statistically significant.
rEsults
Of the 206 GAS isolates tested, all were susceptible to penicillin, vancomycin and linezolid. Erythromycin resistance was observed in 53% (n = 109) of isolates while clindamycin-resistant isolates comprised 33% (n = 69) and all showed inducible resistance. Tetracycline resistance was found in 58% (n = 119) of isolates [ Figure 1 ].
A slight difference was observed in the antibiotic resistance among GAS isolated from invasive and superficial infections. The erythromycin resistance was found in 48% and 55% of invasive and non-invasive isolates, respectively, whereas clindamycin resistance (inducible) was observed in 27% and 36% of invasive and non-invasive isolates, respectively. Tetracycline resistance was slightly higher in non-invasive isolates (62%) when compared with invasive isolates (48%).
The co-occurrence of erythromycin and tetracycline resistance was found in 39% of the total isolates whereas 28% were sensitive to both antibiotics. It was noted that among the erythromycin-resistant isolates, 73% (80/109) were co-resistant.
The MIC 50 and MIC 90 of penicillin were 0.016 µg/ml while 3% of the isolates showed slightly higher MIC values but within the susceptible range. The MIC 50 and MIC 90 of erythromycin were 2 µg/ml and ≥256 µg/ml whereas of tetracycline were 12 µg/ml and 32 µg/ml, respectively [ Table 2 ].
Majority of the erythromycin-resistant isolates (63%) belonged to inducible phenotype (iMLS) followed by the M phenotype (37%). Isolates with M phenotype had lower MIC values (1-12 µg/ml) for erythromycin whereas those with iMLS phenotype showed higher erythromycin MICs (≥256 µg/ ml). Among the macrolide-resistant isolates, 61% harboured ermB and 37% mefA as sole macrolide-resistant gene, whereas the presence of ermB plus mefA (2%) was also observed. Neither the cMLS phenotype nor the ermA gene was observed in the study [ Figure 2 ]. Table 3 illustrates the distribution of macrolide-resistant phenotypes, erythromycin MIC values and genotypes of erythromycin-resistant isolates.
Among the 119 tetracycline-resistant isolates, 97% harboured tetM and the remaining 2% had tetO while one strain carried both tetM and tetO genes [ Figure 3 ]. None of the isolates were positive for tetK and tetL genes. The distribution of tetracycline MIC values and genotypes of tetracycline-resistant isolates is shown in Table 4 .
DiscussiOn
Selection pressure exerted by the inappropriate use of antibiotics is the major driving force for the development of antibiotic-resistant organisms. In India, this is worsened by the over-the-counter availability of antibiotics without any regular surveillance for resistant strains.
The present study comprised 206 GAS isolates from various clinical samples collected over a period of 4 years. All the isolates were fully susceptible to penicillin, vancomycin and linezolid as observed over decades of antibiotic usage. The universal susceptibility of GAS to penicillin could be due to its limited ability to exchange genetic material and acquire new resistance determinants (β-lactamase genes) or the high biological cost incurred (physiological defects, poor growth rates and gross morphological abnormalities) when : CCC GAA AAA TAC GCA AAA TTT CAT  R: CCC TGT TTA CCC ATT TAT AAA CG   590  93°C for 3 min; 30 cycles of 93°C for 1 min 61.8°C for  1 min  65°C for 1 min and final extension of 65°C for 3 min  ermB  F: TGG TAT TCC AAA TGC GTA ATG  R: CTG TGG TAT GGC GGG TAA penicillin-binding proteins undergo mutations that lower their affinity for penicillin. [13] A few previous studies have reported diminished penicillin susceptibility in GAS isolates. Fortunately, the clinical impact of such a finding is minimal as the drug can be given at higher doses without any side effects. [14] Erythromycin resistance was first reported in 1955, and since then, the resistance has been gradually rising worldwide. [6] The proportion of macrolide resistance as well as the prevalent phenotype varies with countries. The rates vary between 5% and 40%, with the highest prevalence in Asia and the lowest prevalence in Europe and the USA. Among the Asian countries, a low macrolide resistance was reported from Lebanon, Turkey and Taiwan, while the resistance was very high in countries such as China, India, Pakistan, Japan and Korea. [6, 15, 16] In the present study, we report an overall macrolide resistance of 53% which is very high when compared with other studies from India. A study by Brahmadathan et al., comprising 1313 GAS isolates collected during 1986-2002, reported about a steady rise in the erythromycin resistance. During 1986-1993, erythromycin resistance was 2.7%, increased to 5.8% in 1999 and reached 13.8% in 2002. [17] Previous Indian studies by Jacob et al., Jain et al. and Lloyd et al. go in line with Brahmadathan et al., with a reported prevalence of 9.04%, 10.2% and 16.2%, respectively. [18, 19, 20] Shivekar and Menon in 2015 reported a slightly higher rate (38%) of macrolide resistance among South Indian GAS isolates. [5] According to the Survey of Antibiotic Resistance 2012-2014, of the 78 GAS isolates collected from four sites across India, erythromycin resistance was 76.3%. [21] In contrary to the above findings, Ray et al., from Eastern India, reported that the erythromycin resistance in GAS was very low (2.85%). [22] A previous study from Puducherry in 2007 revealed that only 1% of the tested GAS isolates (n = 405) were erythromycin resistant. [23] The drastic increase in macrolide resistance can be attributed to the subsequent practice of increased azithromycin prescription for respiratory infections which was uncommon earlier. The macrolide consumption data showed significant difference between the two study periods. The iMLS phenotype was predominant, constituting 63% isolates among our study population. The isolates iMLS phenotype had higher erythromycin MIC values (≥256 µg/ml). The predominance of iMLS phenotype was also reported from Norway and Bulgaria. [24] The M phenotype was the second most commonly encountered accounting for 37% of isolates. The erythromycin MIC for these isolates was very low, 1-12 µg/ml. The streptococci of M phenotype have been reported from European countries, Argentina, the USA and Canada where the prevalence of macrolide resistance is very low. [12] The complete absence of cMLS phenotype reported in the present study was in contrast with the findings from European countries where the cMLS phenotype is common. [25] Another study from India by Shivekar and Menon reported the dominance of iMLS phenotype (55.26%) followed by M (26.32%) and cMLS (18.42%) among the erythromycin-resistant GAS isolates. [5] In contrast, Jacob et al. reported that the M phenotype was the most prevalent. [18] A gene-phenotype correlation was noticed by previous studies, the mefA gene was predominant in isolates with the M phenotype while ermB with cMLS phenotype and ermA with iMLS phenotype, respectively. [26] The molecular basis of macrolide resistance in Indian GAS population has not been explored extensively.
With regard to the genetic determinants of macrolide resistance, our results show that the ermB gene (always associated with the iMLS phenotype) was predominant. This is contrary to the previous reports where ermB gene was always associated with the cMLS phenotype. The mefA gene associated with the M phenotype was the second common genetic determinant. A similar pattern of resistance gene distribution was also previously reported from Belgium, France and Italy whereas the solitary Indian study showed a predominance of ermB gene. [26] [27] [28] High tetracycline resistance in GAS has been reported in many countries even though it is not used in the treatment of GAS diseases. The possible driving forces of this could be the selective pressure from the intensive use of tetracycline to treat a variety of human and veterinary infections and its increased use in animal foods, with the transfer of genes from animals to humans. [8] The tetracycline resistance in our study was 58% which is in line with previous Indian reports. [19, 20, 22] According to the current knowledge, the tetracycline resistance in GAS is mainly mediated by the presence of ribosomal protection proteins (tetM and tetO) and less common by efflux pumps (tetK and tetL). [9] In our study, 97% of the tetracycline-resistant isolates carried tetM gene. These isolates displayed tetracycline MICs ranging from 8 to 48 µg/ml. Hraoui et al. found that majority of the tetracycline-resistant tetM-positive GAS isolates harboured int-Tn gene, demonstrating that tetM is carried by the Tn916-related transposons which easily translocates from chromosome to chromosome. This explains the occurrence of tetM as the major genetic determinant for tetracycline resistance in GAS. [8] The tetO gene was present only in 2% (n = 2) of the tetracycline-resistant isolates and one isolate harboured both tetM and tetO genes. None of the isolates were positive for tetK and tetL genes, demonstrating that the efflux pump-mediated tetracycline resistance is absent in our study population.
Co-occurrence of tetracycline and macrolide resistance has been reported as tetracycline resistance genes can be located on mobile genetic elements carrying macrolide resistance genes. [8, 9] The co-resistance relies mostly on tetM gene and to a lesser extent on tetO gene. [29] With regard to co-resistance, 39% of our study population was co-resistant to both erythromycin and tetracycline. We found that 69% (n = 55) of the co-resistant isolates had iMLS phenotype followed by the M phenotype (31%). A significant association was observed between co-resistance and presence of iMLS phenotype. Similar findings were reported from Finland. [4] In contrast, studies from Athens, Spain and Norway found that co-resistance was associated with the cMLSB macrolide-resistant phenotype. [3, 12, 24] Of the 80 co-resistant isolates, 54 carried tetM/ermB as their only resistance genes, suggesting that these isolates may carry Tn916 family conjugative transposons in which ermB and tetM are linked. [30] In the remaining isolates, 25 carried tetM/mefA genes associated with co-resistance whereas one isolate was positive for tetM, tetO and ermB genes. Previous studies have discussed about the association of tetO and mefA genes in co-resistant isolates, but this study could not establish such linkage. [31] cOnclusiOn The erythromycin and tetracycline resistance continues to exist at high levels and may be attributed to the over-prescription and use of these antibiotics. This issue needs to be addressed with priority and stringent measures to be taken to stop the easy availability of antibiotics not only for human health but also for other industries such as animal livestock, food and agriculture.
